Status:
COMPLETED
Lime Powder Regimen (LPR) for Prevention of Renal Stone Recurrence
Lead Sponsor:
Chulalongkorn University
Collaborating Sponsors:
Sanpasitthiprasong Hospital
Burapha University
Conditions:
Urolithiasis
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Lime powder regimen (LPR) is a lime-derived composition enriches with citrate/citric acid and potassium. LPR was invented to treat the renal stone patients with high risk of stone recurrence after sto...
Detailed Description
Lime powder regimen (LPR) is a mixture of lime-derive component with adjuvants containing high concentration of citrate, and moderate amount of potassium, magnesium and antioxidants. LPR was tested an...
Eligibility Criteria
Inclusion
- Renal stone patients who were identified and stone was removed by surgical method.
Exclusion
- Chronic kidney disease, chronic liver disease, history of coronary artery disease, or person who takes any medication that alters urinary metabolic profiles
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT03258190
Start Date
July 1 2014
End Date
June 30 2018
Last Update
February 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chulalongkorn University
Bangkok, Thailand, 10330